Mark Pruzanski
2013
In 2013, Mark Pruzanski earned a total compensation of $3.3M as Chief Executive Officer and President at Intercept Pharmaceuticals, a 2% decrease compared to previous year.
Compensation breakdown
| Bonus | $475,000 |
|---|---|
| Option Awards | $2,073,500 |
| Salary | $459,000 |
| Stock Awards | $245,630 |
| Other | $4,200 |
| Total | $3,257,330 |
Pruzanski received $2.1M in option awards, accounting for 64% of the total pay in 2013.
Pruzanski also received $475K in bonus, $459K in salary, $245.6K in stock awards and $4.2K in other compensation.
Rankings
In 2013, Mark Pruzanski's compensation ranked 2,306th out of 12,286 executives tracked by ExecPay. In other words, Pruzanski earned more than 81.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,306 out of 12,286 | 81st |
Division Manufacturing | 763 out of 4,612 | 84th |
Major group Chemicals And Allied Products | 207 out of 1,466 | 86th |
Industry group Drugs | 138 out of 1,160 | 88th |
Industry Pharmaceutical Preparations | 116 out of 890 | 87th |
Source: SEC filing on June 20, 2016.
Pruzanski's colleagues
We found three more compensation records of executives who worked with Mark Pruzanski at Intercept Pharmaceuticals in 2013.